Paul J. Angelico - 11 Apr 2022 Form 3 Insider Report for CHEMBIO DIAGNOSTICS, INC.

Signature
/s/ Mark L. Johnson, Attorney-in-Fact for Paul Angelico
Issuer symbol
N/A
Transactions as of
11 Apr 2022
Net transactions value
$0
Form type
3
Filing time
27 Apr 2022, 21:09:09 UTC
Next filing
02 May 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CEMI Common Stock 7,885 11 Apr 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CEMI Incentive stock options 11 Apr 2022 Common Stock 29,883 $5.61 Direct F1
holding CEMI Incentive stock options 11 Apr 2022 Common Stock 65,476 $4.65 Direct F2
holding CEMI Restricted stock units 11 Apr 2022 Common Stock 10,594 Direct F3, F4
holding CEMI Restricted stock units 11 Apr 2022 Common Stock 15,771 Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The incentive stock options are scheduled to vest in three equal installments on October 28 of each of 2020, 2021 and 2022, subject to continued service through each vesting date.
F2 The incentive stock options are scheduled to vest in four equal installments on March 15 of each of 2022, 2023, 2024 and 2025, subject to continued service through each vesting date.
F3 The restricted stock units are scheduled to vest on October 28, 2022, subject to continued service through each vesting date.
F4 Each restricted stock unit represents a contingent right to receive one share of common stock.
F5 The restricted stock units are scheduled to vest in two equal installments on March 15 of each of 2023 and 2024, subject to continued service through each vesting date.

Remarks:

Executive Vice President and Chief Operations Officer Exhibit List: Exhibit 24 - Power of Attorney